Skip to main content
PMC home page
Sexually Transmitted Infections logoLink to Sexually Transmitted Infections
. 1999 Aug;75(4):225–227. doi: 10.1136/sti.75.4.225

What to do with the patient with recurrent vulvovaginal candidiasis

J S Bingham
PMCID: PMC1758221  PMID: 10615306

Full Text

The Full Text of this article is available as a PDF (69.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Davidson F., Mould R. F. Recurrent genital candidosis in women and the effect of intermittent prophylactic treatment. Br J Vener Dis. 1978 Jun;54(3):176–183. doi: 10.1136/sti.54.3.176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Dennerstein G. J. Depo-Provera in the treatment of recurrent vulvovaginal candidiasis. J Reprod Med. 1986 Sep;31(9):801–803. [PubMed] [Google Scholar]
  3. Drutz D. J. Lactobacillus prophylaxis for Candida vaginitis. Ann Intern Med. 1992 Mar 1;116(5):419–420. doi: 10.7326/0003-4819-116-5-419. [DOI] [PubMed] [Google Scholar]
  4. Fidel P. L., Jr, Sobel J. D. Immunopathogenesis of recurrent vulvovaginal candidiasis. Clin Microbiol Rev. 1996 Jul;9(3):335–348. doi: 10.1128/cmr.9.3.335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fidel P. L., Jr Vaginal candidiasis: review and role of local mucosal immunity. AIDS Patient Care STDS. 1998 May;12(5):359–366. doi: 10.1089/apc.1998.12.359. [DOI] [PubMed] [Google Scholar]
  6. Hilton E., Isenberg H. D., Alperstein P., France K., Borenstein M. T. Ingestion of yogurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med. 1992 Mar 1;116(5):353–357. doi: 10.7326/0003-4819-116-5-353. [DOI] [PubMed] [Google Scholar]
  7. Jovanovic R., Congema E., Nguyen H. T. Antifungal agents vs. boric acid for treating chronic mycotic vulvovaginitis. J Reprod Med. 1991 Aug;36(8):593–597. [PubMed] [Google Scholar]
  8. Redondo-Lopez V., Lynch M., Schmitt C., Cook R., Sobel J. D. Torulopsis glabrata vaginitis: clinical aspects and susceptibility to antifungal agents. Obstet Gynecol. 1990 Oct;76(4):651–655. [PubMed] [Google Scholar]
  9. Rigg D., Miller M. M., Metzger W. J. Recurrent allergic vulvovaginitis: treatment with Candida albicans allergen immunotherapy. Am J Obstet Gynecol. 1990 Feb;162(2):332–336. doi: 10.1016/0002-9378(90)90380-p. [DOI] [PubMed] [Google Scholar]
  10. Shinohara Y. T., Tasker S. A. Successful use of boric acid to control azole-refractory Candida vaginitis in a woman with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Nov 1;16(3):219–220. doi: 10.1097/00042560-199711010-00013. [DOI] [PubMed] [Google Scholar]
  11. Sobel J. D., Chaim W. Treatment of Torulopsis glabrata vaginitis: retrospective review of boric acid therapy. Clin Infect Dis. 1997 Apr;24(4):649–652. doi: 10.1093/clind/24.4.649. [DOI] [PubMed] [Google Scholar]
  12. Sobel J. D. Controversial aspects in the management of vulvovaginal candidiasis. J Am Acad Dermatol. 1994 Sep;31(3 Pt 2):S10–S13. doi: 10.1016/s0190-9622(08)81259-5. [DOI] [PubMed] [Google Scholar]
  13. Sobel J. D. Pathogenesis and treatment of recurrent vulvovaginal candidiasis. Clin Infect Dis. 1992 Mar;14 (Suppl 1):S148–S153. doi: 10.1093/clinids/14.supplement_1.s148. [DOI] [PubMed] [Google Scholar]
  14. Sobel J. D. Vulvovaginitis. When Candida becomes a problem. Dermatol Clin. 1998 Oct;16(4):763-8, xii. doi: 10.1016/s0733-8635(05)70043-7. [DOI] [PubMed] [Google Scholar]
  15. White D. J., Emens M., Shahmanesh M. Recurrent vulvovaginal candidosis. Int J STD AIDS. 1991 Jul-Aug;2(4):235–239. doi: 10.1177/095646249100200401. [DOI] [PubMed] [Google Scholar]
  16. White D. J., Johnson E. M., Warnock D. W. Management of persistent vulvo vaginal candidosis due to azole-resistant Candida glabrata. Genitourin Med. 1993 Apr;69(2):112–114. doi: 10.1136/sti.69.2.112. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Publishing Group

RESOURCES